Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April July May June August September October November December
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Gaza doctor speaks of hope and courage
2011-10-21

 
An emotional Dr Izzeldin Abuelaish talks about the loss of his three daughters 
Photo: Johan Roux

Listen to Dr Abuelaish's public lectures (audio)

In 2009 Israeli forces bombed the house of Palestinian doctor Izzeldin Abuelaish killing four people: three of his daughters and a niece. Speaking about this life-changing event, Dr Abuelaish delivered two public lectures at the University of the Free State (UFS) this week spreading the message of hope and peace.

Dr Abuelaish, who was introduced as the Nelson Mandela of Palestine by Prof. Jonathan Jansen, Vice-Chancellor and Rector, spoke emotionally about the loss of his daughters Bessan, Aya and Miyar.  He told the audience that there was no reason for them to be killed. His girls were armed with love, hope and education.

He urged people to have moral courage and encouraged them to strive for justice, truth and peace. When there is justice and truth, peace is a consequence. “As a medical doctor I never lose hope. By the end of this world we will forget what enemies did, but will never forget the silence of brothers.”

Dr Abuelaish spoke passionately about the role of women in society and said a country develops by how much it invests in women’s education. “We must realise the strongest members in a community are women. Women maintain the hope.”

Speaking about his life in the war, being born Palestinian, Dr Abuelaish said it was painful to hear that Palestinians are numbers and statistics. “When a soldier is killed in Iraq or another place, the screen speaks for days about what he ate and what he hoped for, others are figures and numbers.”

Dr Abuelaish, who wrote the book I shall not hate, A Gaza Doctor’s Transformational Journey of loss, Love and Change, said the death of his daughters made him stronger and more focused not to give up. “I swore to my daughters and God not to rest, I fully believe I will meet them one day. I will meet them with the big gift of justice.”  

Visit the website www.daughtersforlife.com to read more about Dr Izzeldin Abuelaish.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept